// App-Quantinova.ai

E028 : Seronegative arthritis in the context of CHIP: is this a new entity that needs further investigation?

Researchers

Presenter

  • Sarah Mohamed

Principal Investigators

  • Thomas Mckerrell

  • Damodaran Makkuni

Medical Centers

  • James Paget University Hospitals, Medicine, Gorleston, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Dermatology

  • Autoimmune (AI)

  • Blood/haematological Diseases

  • Musculoskeletal

Disease

  • Seronegative arthritis

  • Inflammatory Arthritis

  • Psoriatic arthritis

  • Neutropenia

Biomarkers

  • anti-CCP antibodies

  • C reactive protein

  • Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Epsilon

Drug/Treatment

  • Hydroxychloroquine

  • Adalimumab

  • golimumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved